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Highlights 
 Hybrid epicardial and endocardial ablation for atrial fibrillation
 Subxiphoid incision to access the posterior pericardial space
 Radiofrquency ablation of the posterior left atrial wall
 Simultaneous left thoracoscopic approach to occlude the left atrial appendage
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Introduction 
Invasive interventions for atrial fibrillation have advanced considerably since the advent 
of the first Cox-Maze operation (1, 2). The development of catheter based endocardial ablation 
represented a significant shift in the treatment of atrial fibrillation. Advances in ablation 
technology energy sources and techniques have improved both surgical and catheter treatment 
outcomes. Minimally invasive surgical approaches have also incrementally decreased the 
morbidity associated with such procedures (3). Paroxysmal atrial fibrillation is usually well 
controlled with pulmonary vein isolation, and catheter based ablation alone is often quite 
effective for patients with this variant of atrial fibrillation. The optimal treatment of persistent 
and long standing persistent atrial fibrillation, however, remains debated and the success rates of 
single episode catheter ablation alone leave much room for improvement (4). This may be due to 
fundamental histological and molecular differences in the pathophysiology of these variants of 
atrial fibrillation when compared to paroxysmal atrial fibrillation (5). In addition to triggers and 
macro-reentrant circuits, left atrial remodeling and substrate modification may all contribute to 
the difficulty in treating persistent and long standing persistent variants. Furthermore, the 
arrhythmogenic triggers in these patients may also originate in locations outside of the 
pulmonary veins, including the posterior left atrium and left atrial appendage (5). This has led 
investigators to consider alternative and adjunctive ablation strategies for these patients, 
including ablation and isolation of the posterior left atrial wall.  
Recently, a novel hybrid approach was developed to facilitate ablation in symptomatic 
persistent and long standing persistent atrial fibrillation without the need for sternotomy or 
cardiopulmonary bypass. This multidisciplinary approach, called the Convergent Procedure, 
consists of a minimally invasive surgical epicardial ablation of the posterior left atrial wall 
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followed by catheter based endocardial ablation with pulmonary vein isolation (6). Both the 
cardiac surgeon and electrophysiologist must work together for success of the Convergent; the 
surgical or endocardial procedure alone is insufficient to effect full treatment. Herein lies the 
strength of the Convergent—it is a truly hybrid approach that combines the advantages of 
surgical and catheter approaches to maximize successful outcomes while minimizing risks in this 
difficult patient population (8, 9, 10). 
The left atrial appendage can also be managed with epicardial occlusion at the time of 
Convergent surgery via left video-assisted thoracoscopic (VATS) approach (11). Epicardial 
closure of the left atrial appendage confers benefits from both a thromboembolism reduction 
aspect as well as arrhythmia control aspect. The left atrial appendage has been shown to harbor 
triggers for atrial fibrillation, and the epicardial clip excludes the appendage while also 
conferring electrical silence. This antiarrhythmic benefit is one advantage of the epicardial clip 
closure over current percutaneous closure options. The target patient population for the 
Convergent Procedure with or without left atrial appendage closure are patients with 
symptomatic persistent or long standing persistent atrial fibrillation refractory to medical 
management or catheter ablation. The two portions (surgical and catheter) can be performed 
either simultaneously (in an EP laboratory or hybrid OR), back-to-back on the same day (in the 
OR followed by EP laboratory), or staged apart by several weeks. At the time of this writing 
there is no data indicating superiority of one method of scheduling over the others. 
We describe here our technique for the surgical portion of the Convergent Procedure 
along with left atrial appendage closure by epicardial clip placement through a left VATS 
approach. 
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Figures & Illustrations 
 
Figure 1 – Positioning and Incision 
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The patient is positioned supine with an inflatable bump under the left thorax. Arterial 
monitoring line is placed. A central venous line and/or two large bore peripheral IV lines are 
placed. Intubation is performed with either a bronchial blocker or double lumen endotracheal 
tube to allow for single lung ventilation (right lung ventilation, left lung decompression) later 
during the VATS portion. If the left VATS part of the operation will not be performed, 
intubation can be done with a regular single lumen endotracheal tube. Transesophageal 
echocardiography (TEE) is performed to ensure no thrombus in the left atrium or atrial 
appendage. Esophageal temperature probe is then placed under fluoroscopic guidance such that 
the tip of the probe is located 1.5 to 2 vertebral bodies below the carina. 
An approximately 4 cm incision is made over the xiphoid process. The soft tissue is 
divided and the xiphoid process excised. The mediastinal soft tissue is dissected and the 
pericardium identified. The use of narrow malleable ribbon retractors can aid in this exposure, 
especially in obese patients. The caudad aspect of the anterior pericardium is incised to create a 
pericardial window of approximately 3-4 cm in length. The pericardial incision can be extended 
if necessary. Pericardial fluid is aspirated. 
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Figure 2 – Insertion of the Pericardioscopy Cannula 
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The pericardioscopy SUBTLE
TM
 Cannula (AtriCure Inc, Mason, OH) is prepared by 
connecting to appropriate suction and irrigation lines. The Cannula is then inserted gently into 
the pericardial space. Retraction of the inferior/caudal aspect of the pericardium with a malleable 
ribbon placed into the pericardial space can allow for opening of the window and assist with 
insertion of the Cannula. A 5 mm 0 degree scope is then inserted through the Cannula. At the 
time of Cannula insertion the surgeon should notify anesthesia of a possible drop in blood 
pressure due to mechanical compression. Hemodynamic changes, should they occur, are usually 
only transient. As shown here, the Cannula should course toward the posterior pericardial space 
behind the left ventricle and left atrium. 
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Figure 3 – Identification of Anatomic Landmarks 
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Using the Cannula and 5 mm scope, the posterior pericardial space is explored. Care is 
taken to ensure that the cleft of the Cannula is aimed toward the heart and the beveled tip of the 
Cannula is always oriented toward the pericardium. Gentle clockwise and counter-clockwise 
twisting of the Cannula can help maneuver within the pericardial space. Relevant anatomy must 
be identified:  1) coronary sinus, 2) left inferior pulmonary vein, and 3) right inferior pulmonary 
vein. The inset circles show photographs of intraoperative views of these structures through the 
scope. The superior pulmonary veins are usually not visible due to limitations from the superior 
pericardial reflections. Upon insertion of the scope into the Cannula, the first structure usually 
encountered in the coronary sinus. Advancing the Cannula to the patient’s right side from the 
coronary sinus will bring the left atrium into view. Movement of the Cannula “forward” in the 
cephalad direction will then expose the left inferior pulmonary vein. Sweeping the Cannula and 
scope further to the patient’s right will then bring the right inferior pulmonary vein into view. 
Once these three landmark structures above have been clearly identified, ablation can begin.  
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Figure 4 – Insertion of Ablation Catheter 
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The EPi-Sense
TM
 Coagulation Device (AtriCure, Inc, Mason, OH) monopolar radiofrequency 
catheter is inserted through the pericardioscopy Cannula. This illustration is not of the surgeon’s 
view through the camera scope; rather, this illustration is intended to show the position of the 
Cannula and the ablation catheter in relation to the heart.  
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Figure 5 –Posterior Left Atrial Ablation, Continued 
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We start ablation lines adjacent to the left pulmonary veins (top left figure). Exposure is 
obtained and the ablation catheter is inserted in the cephalad direction until resistance is met. The 
goal is to place the ablation catheter as far superior as possible; this superior extent will be 
limited and dictated by the patient’s pericardial reflections. Suction is applied and the ablation 
catheter is latched onto the epicardium. The baseline esophageal temperature is noted. Saline is 
infused into the field and ablation initiated. The surgeon must confirm that the ablation 
electrodes are facing toward the heart and not toward the pericardium. Radiofrequency energy is 
applied for 90 seconds to create a transmural ablation line. Sequential ablation lines are created 
moving toward the right pulmonary veins, ensuring that each ablation line is slightly overlapping 
the previous lesion (top right figure).  
Ablating immediately adjacent to the right pulmonary veins can be somewhat challenging 
due to the angle of the pulmonary vein-posterior wall junction. Using the Cannula and camera 
scope to push the ablation catheter up against the left atrial wall in this region can assist in 
achieving proper positioning for ablation. Once the superior (cephalad) ablation row is 
completed, the inferior row can be started. The ablation catheter is placed caudad, or inferior, to 
the first row but such that there is slight overlap with the first row (bottom left figure). Sequential 
ablation lesions are created, progressing back toward the left pulmonary veins (bottom right 
figure).  
This second row of ablation should not proceed caudad to the inferior pulmonary veins; 
the isthmus region between the inferior pulmonary veins and the coronary sinus should not be 
ablated as this could lead to induction of left atrial flutter. Furthermore, care is taken to avoid 
ablation too close to the coronary sinus or the atrioventricular groove. Once both rows of 
ablation are completed, the posterior wall is visually inspected to ensure complete epicardial 
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coverage of the visible portion of the posterior wall. The goal is to have a continuous area of 
ablation extending from pulmonary vein to pulmonary vein. The anterior portions of the 
pulmonary veins on either side can also be ablated, although a full pulmonary vein isolation is 
not possible due to pericardial reflections. To ablate the left inferior pulmonary vein, the left 
inferior pulmonary vein is visualized and then the left ventricle lifted, exposing just a small part 
of the space anterior to the vein. The ablation catheter is inserted into this space and rotated such 
that the electrodes are pointing toward the area where the vein meets the atrium. This maneuver 
can cause substantial hypotension and thus must be performed in close communication with the 
anesthesia team. 
Of note, the esophageal temperature is continuously monitored throughout the entire 
ablation procedure, and if this temperature rises 1 degree Centigrade above baseline at any point 
then the ablation is stopped and saline infused into the pericardial space to allow the temperature 
to return to baseline. 
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Figure 6 – Closure 
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A 19 Fr drain is placed through the Cannula and into the pericardial well. This is brought 
out through a separate stab incision and secured in place. The soft tissue is then closed in 
multiple layers.  
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Figure 7 – Left VATS Approach for Left Atrial Appendage Closure 
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Single lung ventilation is commenced, allowing the left lung to deflate. The inflatable 
bump underneath the left thorax is inflated to effect a small rise in the left chest. The operating 
table can be positioned in reverse Trendelenburg and tilted rightward to help with positioning. A 
5 mm port is inserted at approximately the 4
th
 interspace along the mid-axillary line. A 5 mm 30 
degree scope is inserted and pleural cavity visually explored. CO2 insufflation is initiated to aid 
with exposure. Once the left lung is satisfactorily deflated and no pleural adhesions are 
identified, additional ports are inserted. The outline of the left atrial appendage can sometimes be 
seen within the pericardial sac. A 5 mm port is inserted at approximately the 6
th
 interspace in the 
mid-axillary line. The phrenic nerve must be clearly identified. Next, the pericardium is incised 
about 1-2 cm posterior to the phrenic nerve using a hook tip electrocautery on low settings. 
Alternatively, different advanced energy devices can be used (e.g., bipolar radiofrequency, 
ultrasonic, etc.). The incision is carried caudally about midway toward the ventricular apex and 
cephalad up to at least the level of the superior edge of the left atrial appendage. This pericardial 
incision can be carried as far cephalad as the pulmonary artery as long as the vessel is clearly 
visualized and care taken to avoid injury. Another 5 mm port is then inserted at the 2
nd
 interspace 
near the anterior axillary line. This port will be used primarily for retraction of the pericardium. 
The inset circle identifies the usual placement and location of the ports. 
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Figure 8 – Left Atrial Appendage Exposure and Clip Sizing 
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Two endo-Kitner retractors are used to reflect the pericardium up to expose the left atrial 
appendage. Care must be taken to ensure that excessive retraction force is not applied to the 
phrenic nerve. Alternatively, an endoscopic suturing device can be used to place a suture on the 
anterior (upper) edge of the pericardiotomy and brought out through the anterior chest wall to aid 
with self-retraction. Once the appendage is exposed, the base is measured using a sizing ruler. 
The left atrial appendage exclusion device utilized is the AtriClip PRO2
TM 
Device (AtriCure Inc, 
Mason, OH). The majority of patients will size to a 35 or 40 mm clip.  If an endoscopic suturing 
device was utilized for self-retaining retraction of the anterior pericardial edge, then the port that 
is already in the 6
th
 interspace can be extended and converted to a 12 mm port. If no endoscopic 
self-retaining suture was placed, then a fourth and final port is a 12 mm port placed at 
approximately the 7
th
 interspace about halfway between the mid and posterior axillary lines. The 
epicardial clip will be inserted through this 12 mm port. 
Downloaded for Anonymous User (n/a) at Indiana University - Ruth Lilly Medical Library from ClinicalKey.com by Elsevier on May 03, 2019.
For personal use only. No other uses without permission. Copyright ©2019. Elsevier Inc. All rights reserved.
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
Figure 9 – Left Atrial Appendage Clip Placement 
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The appropriate sized clip delivery device is inspected and tested to ensure proper 
articulation and movement. Real time TEE is performed at this point to visualize the appendage. 
The epicardial clip delivery device is then inserted through the 12 mm port and the clip is gently 
maneuvered around the left atrial appendage. Close communication with anesthesia and the 
echocardiographer is essential. 
First, the distal tip of the epicardial clip is positioned around the appendage. An endo-
Kitner is used to help gently manipulate the appendage tissue into the clip. The appendage 
should not be grasped using instruments as this can result in perforation or tear of the fragile 
tissue. Positioning of the clip at the base of the appendage is confirmed by visualizing complete 
encirclement starting at the atrio-ventricular groove and both the proximal and distal ends of the 
clip. It is important to ensure that all lobes of the appendage are within the clip. Following this, 
the clip is then gently rotated in a clockwise direction about the axis of the delivery device while 
the remainder of the atrial tissue is teased into the clip with the endo-Kitner. This maneuver is 
critical to ensure that all lobes of the appendage as well as tissue along the cephalic side (toward 
the pulmonary veins) of the appendage are enclosed within the clip. Undesirable residual stumps 
are usually located toward this portion of the left atrium and appendage. Once the entire 
appendage is excluded, the clip is closed with simultaneous visualization on TEE. The left atrial 
appendage should disappear from view on the TEE with minimal to no residual appendage 
stump. Electrocardiogram is checked to ensure no ischemic changes are seen, as placement onto 
the AV groove can cause kinking or compression of the circumflex coronary artery.  
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Figure 10 – Left Atrial Appendage Exclusion and Chest Tube Placement and Closure 
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Once complete closure of the left atrial appendage without residual stump is confirmed, 
and there are no electrocardiographic changes, the clip can be deployed. The surgeon must be 
completely satisfied with the positioning of the clip, as once it is released, the clip cannot be 
moved or re-positioned. The delivery device is then removed. The left atrial appendage will 
quickly attain a dark, ischemic discoloration. We do not incise the tip of the appendage to drain 
the indwelling blood. 
A 28 Fr Blake tube is placed under thoracoscopic vision into the left pleural cavity. Ports 
are removed and hemostasis obtained. Expansion of the left lung is visualized before removal of 
the final port. The incisions are closed in layers and local anesthesia applied. 
 
Discussion 
We have described our technique for the surgical portion of the Convergent Procedure 
and concomitant left VATS left atrial appendage exclusion. Patients most likely to benefit from 
this procedure are those with symptomatic persistent or long-standing persistent atrial fibrillation 
who desire a rhythm control strategy to treat the arrhythmia. All of our patients undergoing the 
Convergent Procedure have failed medical management. The majority of our patients are de novo 
(with no prior ablation procedures), although a substantial number have also failed either one or 
more prior catheter ablations. This latter group are candidates for this hybrid approach since the 
Convergent Procedure offers an alternative method of addressing the posterior left atrium 
compared to catheter ablation. In these patients who have had prior catheter ablation and undergo 
the surgical portion of the Convergent Procedure, we find it beneficial to still perform (after the 
surgical part) at least an electrophysiology study and mapping with possible repeat endocardial 
ablation.  
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In general, contraindications for the Convergent Procedure are a history of either prior 
cardiac surgery or mediastinal radiation, both of which can make access and identification of 
appropriate anatomy difficult. We do not necessarily follow a strict left atrial size cutoff to 
determine candidacy for the Convergent Procedure, although we expect larger atrial size to 
correspond with lower long term success rates (7). Pre-operative imaging studies include 
echocardiography to assess overall cardiac and valve function, and chest computed tomography 
to assess pulmonary vein anatomy. As described above, in the operating room on the day of 
surgery we perform TEE to evaluate the left atrium and appendage for thrombus.  
The postoperative course following the Convergent Procedure is relatively unremarkable, 
with the greatest difficulty being related to post-procedural pericarditis and pericardial effusion. 
We administer a pre-defined medical regimen to mitigate the effects of pericarditis in the peril-
operative period. Perhaps most importantly, all Convergent patients should have a post-discharge 
echocardiogram to evaluate for postoperative pericardial effusion; pericardial tamponade, though 
rare, is the most serious, and potentially fatal, complication that can occur. Patients who undergo 
concomitant left VATS appendage management are less likely to have pericardial tamponade 
since the lateral pericardiotomy (performed as part of the left atrial appendage procedure) allows 
for drainage of any pericardial fluid into the pleural space.  
Regardless of how the endocardial portion is scheduled, the Convergent Procedure is a 
viable option in the treatment armamentarium against symptomatic persistent and long-standing 
persistent atrial fibrillation. Short and long term results for the Convergent Procedure have been 
promising with acceptable safety profiles (8, 9, 10). We follow current Heart Rhythm Society 
guidelines for a three month post-ablation blanking period before evaluating for arrhythmia 
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recurrence. Post-procedure rhythm monitoring can be performed via either Holter monitoring or 
longer term implantable monitoring devices, depending on institutional preference. 
The Convergent Procedure differs from other minimally invasive surgical ablation 
operations in that the major surgical focus of the Convergent Procedure is the posterior left 
atrium. With the Convergent Procedure, pulmonary vein isolation is performed primarily by 
endocardial approach, whereby in other minimally invasive surgical ablation procedures (such as 
bilateral thoracoscopic approach), pulmonary vein isolation is performed by epicardial ablation 
in the operating room (12). Such minimally invasive surgical ablation procedures also usually 
require a subsequent endocardial study and mapping with focal catheter ablation of any 
necessary regions, similar to the Convergent Procedure.  
Although there is no definitive data as of yet, we believe appendage exclusion performed 
at the time of Convergent confers a significant benefit by contributing to both arrhythmia control 
and reduction of cardiogenic thromboembolism risk. Patients with pulmonary dysfunction who 
may not tolerate single lung ventilation can still undergo the Convergent epicardial ablation 
without left atrial appendage exclusion. As with any invasive operation, appropriate patient 
selection is paramount in maximizing therapeutic success and minimizing procedural risks. By 
leveraging the strengths of both surgical and percutaneous expertise, the Convergent Procedure 
offers a true hybrid, interdisciplinary paradigm with which to approach a challenging disease 
process.  
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